FWM
KERX

Frontier Wealth Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Frontier Wealth Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-42,660
Closed -$174K – 433
2018
Q1 		$174K Sell
42,660
-1,500
-3% -$6.99K 0.02% 366
2017
Q4 		$205K Sell
44,160
-13,500
-23% -$74.4K 0.03% 329
2017
Q3 		$409K Sell
57,660
-9,400
-14% -$67.6K 0.06% 258
2017
Q2 		$485K Sell
67,060
-4,050
-6% -$25.3K 0.07% 228
2017
Q1 		$438K Sell
71,110
-800
-1% -$4.38K 0.07% 243
2016
Q4 		$421K Sell
71,910
-4,600
-6% -$25.1K 0.07% 241
2016
Q3 		$406K Sell
76,510
-3,200
-4% -$17.3K 0.06% 234
2016
Q2 		$528K Sell
79,710
-1,700
-2% -$9.51K 0.08% 200
2016
Q1 		$380K Sell
81,410
-3,000
-4% -$12K 0.03% 228
2015
Q4 		$426K Sell
84,410
-13,000
-13% -$61.8K 0.07% 216
2015
Q3 		$343K Buy
97,410
+20,525
+27% +$137K 0.05% 237
2015
Q2 		$767K Buy
+76,885
New +$824K 0.12% 153

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.19B AUM 38.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frontier Wealth Management's KERX Position: Q2 2018 in Review

Frontier Wealth Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2018, closing a stake of 42,660 shares — an estimated $174K sold.

Frontier Wealth Management first reported a position in KERX in Q2 2015 and held it in 12 quarters. The position peaked at $767K in Q2 2015. 132 funds tracked by Wall St. Rank hold KERX as of Q2 2018.

  • Frontier Wealth Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
  • Frontier Wealth Management sold 42,660 Keryx Biopharmaceuticals Inc shares in Q2 2018, an estimated $174K.
  • Frontier Wealth Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2015 and held it in 12 quarters.
  • Frontier Wealth Management's Keryx Biopharmaceuticals Inc position peaked at $767K in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2018.

Based on Frontier Wealth Management's 13F filing for Q2 2018, filed 14 Aug 2018.